ライフサイエンスコーパス: pulmonary vein

1 atrial and 6 segments around the ipsilateral pulmonary veins.

2 a3d) is crucial for the normal patterning of pulmonary veins.

3 ause of reconnections in previously isolated pulmonary veins.

4 ntracellular recordings from isolated canine pulmonary veins.

5 anglionated plexi (GP) adjacent to the right pulmonary veins.

6 lungs showed ectatic pulmonary arteries and pulmonary veins.

7 metastases, 3; direct tumor infiltration via pulmonary vein, 1; local relapse of primary sarcoma afte

8 to relieve 59 lesions (pulmonary artery=26, pulmonary vein=21, and superior vena cava=12).

9 ent AF rotors or focal sources that lay near pulmonary veins (22.8%), left atrial roof (16.0%), and e

10 elets (92), with pulmonary vein (69) and non-pulmonary vein (62) focal sites.

11 erns of AF were multiple wavelets (92), with pulmonary vein (69) and non-pulmonary vein (62) focal si

12 As a result, 393 pulmonary veins (7 patients with common ostium) were suc

13 r and anterior-inferior segments of the left pulmonary veins (7.2g and 7.9g).

14 isovolumic relaxation time, mitral E/E', and pulmonary vein A wave duration.

15 lar capillary dysplasia with misalignment of pulmonary veins, a lethal congenital disorder, which is

16 ong candidate gene as it is expressed in the pulmonary veins, a source of AF in many individuals.

17 could be identified using a porcine model of pulmonary vein ablation and an extracorporeal circulatio

18 hen performed in addition to circumferential pulmonary vein ablation and linear ablation.

19 phased radiofrequency multielectrode system (pulmonary vein ablation catheter [PVAC], Medtronic, Inc,

20 etected mostly during energy delivery in the pulmonary vein ablation catheter groups, whereas a relat

21 quency pulmonary group 2), and with regime a pulmonary vein ablation catheter with an aggressive anti

22 prospective Mesh Ablator versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial

23 Circumferential pulmonary vein ablation was performed followed by roof a

24 re randomized study compared circumferential pulmonary vein ablation+linear ablation (control arm) ve

25 blation (control arm) versus circumferential pulmonary vein ablation+linear ablation+complex fraction

26 onchial fistula as a late complication after pulmonary vein ablation, leading to septic air emboli an

27 During right superior pulmonary vein ablation, the PN was paced at 60 beats pe

28 to medical therapy versus cryoballoon-based pulmonary vein ablation.

29 ho was readmitted to hospital 2 months after pulmonary vein ablation.

30 lar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a rare, neonatally lethal d

31 lar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV), with parent-of-origin effects

32 recording system, testing the feasibility of pulmonary vein and cavo-tricuspid isthmus ablation.

33 -second duration) lesions were formed at the pulmonary vein and cavo-tricuspid isthmus.

34 monstrates a clonal relationship between the pulmonary vein and progenitors of the left venous pole.

35 cterized by progressive obstruction of small pulmonary veins and a dismal prognosis.

36 on characterized by the obstruction of small pulmonary veins and a dismal prognosis.

37 initiated by ectopic beats arising from the pulmonary veins and atrium, but the source and mechanism

38 ng persistent AF, limited ablation targeting pulmonary veins and documented nonpulmonary vein trigger

39 nsisted of acute electrical isolation of all pulmonary veins and freedom from recurrent symptomatic a

40 o activation time dispersion adjacent to the pulmonary veins and increased vulnerability to rhythm di

41 Electric isolation of the pulmonary veins and posterior left atrium with a single

42 lure (HF) leads to predominate remodeling of pulmonary veins and that the severity of venous remodeli

43 All 4 pulmonary veins and the left atrium posterior wall were

44 n arteriolar walls, anomalous and misaligned pulmonary veins, and reduced pulmonary surfactant secret

45 Signal intensities around the left and right pulmonary vein antra and along the LA roof and mitral li

46 ess 2 ablation strategies for persistent AF: pulmonary vein antral isolation (PVAI) in sinus rhythm a

47 n of LSP atrial fibrillation, in addition to pulmonary vein antrum and posterior wall isolation, abla

48 eft atrial isolated surface area (ISA) after pulmonary vein antrum isolation for paroxysmal atrial fi

49 THODS AND Eighty-one patients presenting for pulmonary vein antrum isolation for treatment of AF unde

50 w voltage from electroanatomic maps from the pulmonary vein antrum isolation procedure.

51 ed for AF recurrence at least 6 months after pulmonary vein antrum isolation, with an average follow-

52 e as a predictor for long-term success after pulmonary vein antrum isolation.

53 ollowed by Bachmann's bundle (N=27, 12%) and pulmonary vein area (N=19, 9%; P<0.001).

54 e, the left atrioventricular groove, and the pulmonary vein area was performed during SR in 381 patie

55 However, residual pulmonary vein arrhythmogenicity is a common mechanism o

56 nferior caval, total pulmonary artery, total pulmonary vein, ascending and descending aortic flows (Q

57 days 21 to 35 and major remodeling of small pulmonary veins associated with foci of intense microvas

58 n murine and human hearts that populated the pulmonary veins, atria, and atrioventricular canal.

59 PH was created in Yorkshire swine by partial pulmonary vein banding.

60 ood in early stages, we investigated CTCs in pulmonary vein blood accessed during surgical resection

61 rmation, and facilitated triggered firing in pulmonary veins by local autonomic nerve stimulation.

62 , 9.4 vs 7.7; image quality, 125 vs 28), and pulmonary veins (CNR, 6.2 vs 4.9; image quality, 914 vs

63 Adenosine can unmask dormant pulmonary vein conduction after isolation.

64 ammed electrical stimulation near the murine pulmonary vein demonstrates increased susceptibility to

65 nd C, respectively (P<0.01 for all); coronal pulmonary vein diameter decreased by a median of 16% (IQ

66 Moderate PVN was defined as a pulmonary vein diameter reduction of 25 to 50%, and seve

67 Axial pulmonary vein diameter shortened by a median of 16% (in

68 Pulmonary vein diameter was measured in a coronal and ax

69 Although treatment strategies including pulmonary vein dilation and stenting have been described

70 hal congenital disorder that occurs when the pulmonary veins do not connect normally to the left atri

71 al strand (MES), the precursor of the common pulmonary vein, does not form at the proper location on

72 hich fibrosis underlies the degradation of a pulmonary vein ectopic beat into AF.

73 ar radiofrequency isolation of the bilateral pulmonary vein, ganglionated plexi ablation, and left at

74 cing of SEMA3D in individuals with anomalous pulmonary veins identified a phenylalanine-to-leucine su

75 specific symptoms and the need for dedicated pulmonary vein imaging.

76 f cryotherapy during cryoballoon ablation of pulmonary veins is still unclear.

77 ted atrial electrograms (CFAEs) after antral pulmonary vein isolation (APVI) further improves the cli

78 Empiric circumferential pulmonary vein isolation (CPVI) has become the therapy o

79 to compare arrhythmia-free survival between pulmonary vein isolation (PVI) and a stepwise approach (

80 cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical ou

81 es recommend a 3-month blanking period after pulmonary vein isolation (PVI) as early recurrence of at

82 nd-generation cryoballoon delivers effective pulmonary vein isolation (PVI) associated with superior

83 can be challenging, often involving not only pulmonary vein isolation (PVI) but also additional linea

84 gate whether the combination of conventional pulmonary vein isolation (PVI) by circumferential antral

85 Pulmonary vein isolation (PVI) for atrial fibrillation i

86 Pulmonary vein isolation (PVI) for persistent atrial fib

87 For the past decade, electric pulmonary vein isolation (PVI) has become a procedure im

88 s the impact of CFAE ablation in addition to pulmonary vein isolation (PVI) in patients undergoing ab

89 Pulmonary vein isolation (PVI) is a recommended treatmen

90 The single-procedure efficacy of pulmonary vein isolation (PVI) is less than optimal in p

91 Pulmonary vein isolation (PVI) is still associated with

92 It is not known whether complete pulmonary vein isolation (PVI) is superior to incomplete

93 tions include not only the durability of the pulmonary vein isolation (PVI) lines, but also the patho

94 We hypothesized that pulmonary vein isolation (PVI) plus ablation of selectiv

95 Despite the fact that pulmonary vein isolation (PVI) should be performed proph

96 confidence level >7 were ablated followed by pulmonary vein isolation (PVI).

97 ith obstructive sleep apnea (OSA) undergoing pulmonary vein isolation (PVI).

98 AF/AT recurrence is common after pulmonary vein isolation (PVI).

99 nitial ablation strategy was circumferential pulmonary vein isolation (PVI).

100 resistant hypertension who were referred for pulmonary vein isolation (PVI).

101 transesophageal echocardiogram (TEE) before pulmonary vein isolation (PVI); and 2) the relationship

102 in patients undergoing robotically assisted pulmonary vein isolation (RA-PVI) as compared with manua

103 brillation (AF) recurrences than wide antral pulmonary vein isolation (wide antral isolation [WAI]) b

104 Pulmonary vein isolation alone cannot explain the discre

105 ad undergone cardiac surgery exclusively for pulmonary vein isolation and 17 had no structural heart

106 During video-assisted thoracoscopic surgical pulmonary vein isolation and CARTO mapping, BrS patients

107 ry, 14 months; Q1-Q3, 7-36 months) underwent pulmonary vein isolation and completed the entire follow

108 ents with nonparoxysmal AF undergoing antral pulmonary vein isolation and nonpulmonary vein trigger a

109 CA consisted of linear antral pulmonary vein isolation and optional additional lines.

110 CA included pulmonary vein isolation and posterior wall isolation.

111 nt AF and 22 with long-lasting AF, underwent pulmonary vein isolation and substrate modification of c

112 We performed pulmonary vein isolation and voltage mapping in 236 pati

113 le-lung transplantation surgery both involve pulmonary vein isolation because of suture lines.

114 en; 61 long-lasting persistent AF) underwent pulmonary vein isolation followed by electrogram-guided

115 urrence substantially limits the efficacy of pulmonary vein isolation for AF and is associated with p

116 THODS AND Ten consecutive patients underwent pulmonary vein isolation for persistent atrial fibrillat

117 Contact force parameters evaluated during pulmonary vein isolation for treating atrial fibrillatio

118 Although pulmonary vein isolation has become a mainstream therapy

119 ducibility of atrial fibrillation (AF) after pulmonary vein isolation has been used to guide addition

120 Pulmonary vein isolation has increasingly been used to c

121 In humans, variability of CF during pulmonary vein isolation has not been characterized.

122 hereas CFAE ablation in addition to standard pulmonary vein isolation improves outcomes in patients w

123 acute), and later than 3 months (late) after pulmonary vein isolation in 25 patients with paroxysmal

124 se, Geneva, Switzerland) was used to perform pulmonary vein isolation in 46 patients with paroxysmal

125 lation strategies in the LAAI group included pulmonary vein isolation in 50 (100%), left atrial isthm

126 -13 minutes for STA (P<0.001) with confirmed pulmonary vein isolation in all patients.

127 e targeted for ablation, in conjunction with pulmonary vein isolation in most patients (n=19; 79%).

128 ce atrial fibrillation (AF) recurrence after pulmonary vein isolation in patients with paroxysmal AF.

129 The use of second-generation cryoballoon for pulmonary vein isolation in patients with paroxysmal atr

130 ) and cryoballoon catheter (CB) ablation for pulmonary vein isolation in patients with paroxysmal atr

131 g CFAEs have been compared with the standard pulmonary vein isolation in persistent as well as paroxy

132 for prevention of early AF recurrences after pulmonary vein isolation in the absence of antiarrhythmi

133 modification in addition to circumferential pulmonary vein isolation irrespective of AF type.

134 Pulmonary vein isolation is an effective treatment for A

135 Pulmonary vein isolation is an established treatment opt

136 Pulmonary vein isolation is better than antiarrhythmic m

137 Pulmonary vein reconnection after pulmonary vein isolation is common and is usually associ

138 its high success and low complication rate, pulmonary vein isolation is expected to be increasingly

139 rial fibrillation (AF) failing to respond to pulmonary vein isolation is important.

140 Pulmonary vein isolation is the cornerstone of ablation

141 Pulmonary vein isolation is the most prevalent approach

142 Although pulmonary vein isolation of any means/energy source is t

143 l fibrillation before electric cardioversion/pulmonary vein isolation or after cardioembolic cerebrov

144 Ablation was performed by circumferential pulmonary vein isolation plus linear ablation of extrapu

145 reablation after a previously failed initial pulmonary vein isolation procedure were eligible for thi

146 ODS AND We analyzed 42 CF-guided ipsilateral pulmonary vein isolation procedures.

147 CF during pulmonary vein isolation remains highly variable despite

148 ion to investigate the hypothesis that acute pulmonary vein isolation results from a combination of i

149 e of second-generation 28-mm cryoballoon for pulmonary vein isolation results in an 80% 1-year succes

150 The contact force during pulmonary vein isolation should be a target of 10-20 g o

151 icular contractions at the large majority of pulmonary vein isolation sites.

152 ciation between LAPEF and recurrent AF after pulmonary vein isolation that persisted after multivaria

153 onitoring in the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction El

154 on techniques may facilitate safe and simple pulmonary vein isolation to treat paroxysmal atrial fibr

155 ed tomography (CT) before and 3 months after pulmonary vein isolation using duty-cycled phased radio

156 balloon (LB) with wide-area circumferential pulmonary vein isolation using irrigated radiofrequency

157 imilar efficacy as wide-area circumferential pulmonary vein isolation using irrigated RF in patients

158 tiarrhythmic drug(s), who were scheduled for pulmonary vein isolation using second-generation cryobal

159 ulceration and fistula are complications of pulmonary vein isolation using thermal energy sources.

160 educing AF recurrence, SOE was high favoring pulmonary vein isolation versus antiarrhythmic medicatio

161 Multielectrode pulmonary vein isolation versus single tip wide area cat

162 udy included 140 patients (43 women) in whom pulmonary vein isolation was performed using a second-ge

163 Pulmonary vein isolation was performed with a cryoballoo

164 th paroxysmal atrial fibrillation undergoing pulmonary vein isolation were followed for 12 months wit

165 etic resonance pulmonary vein mapping before pulmonary vein isolation were included.

166 Ablation included pulmonary vein isolation with confirmed entrance block a

167 had similar rates of single-procedure acute pulmonary vein isolation without serious adverse events

168 ) and the surgical maze procedure (including pulmonary vein isolation) done during other cardiac surg

169 atients undergoing CF-guided circumferential pulmonary vein isolation, 914 radiofrequency application

170 After successful pulmonary vein isolation, a bonus freeze was applied.

171 ablation using a stepwise ablation approach (pulmonary vein isolation, electrogram-guided, and linear

172 went epicardial thoracoscopic radiofrequency pulmonary vein isolation, linear ablation, Marshal ligam

173 In CF-guided pulmonary vein isolation, PVR is explained by lack of bo

174 ablation at these sites, in conjunction with pulmonary vein isolation, resulted in AF termination or

175 In addition to pulmonary vein isolation, substrate modification and tri

176 risk of pulmonary vein narrowing (PVN) after pulmonary vein isolation, using a novel multi-electrode

177 s circular lesions, deep enough for electric pulmonary vein isolation, were created with a single cir

178 in the left atrium and coronary sinus after pulmonary vein isolation, were enrolled.

179 paroxysmal AF who were scheduled to undergo pulmonary vein isolation.

180 0 patients; 28%) underwent cryoballoon-based pulmonary vein isolation.

181 ed during sinus rhythm after circumferential pulmonary vein isolation.

182 xation time on CMR and freedom from AF after pulmonary vein isolation.

183 ong association with late recurrent AF after pulmonary vein isolation.

184 All patients underwent successful pulmonary vein isolation.

185 (focal impulse and rotor modulation) before pulmonary vein isolation.

186 AD) therapy in patients with previous failed pulmonary vein isolation.

187 mber of patients with nonparoxysmal AF after pulmonary vein isolation.

188 as terminated in 20 patients (38%) after the pulmonary vein isolation.

189 required spot-ablations to complete electric pulmonary vein isolation.

190 is a novel, nonthermal ablation modality for pulmonary vein isolation.

191 nd may require more extensive treatment than pulmonary vein isolation.

192 fibrillation after contact force (CF)-guided pulmonary vein isolation.

193 Patients with paroxysmal AF underwent pulmonary vein isolation.

194 ed during sinus rhythm in 22 patients before pulmonary vein isolation.

195 before video-assisted thoracoscopic surgical pulmonary vein isolation.

196 h a conventional ablation approach was used (pulmonary vein isolation/stepwise approach).

197 fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the bia

198 Current guidelines recommend pulmonary-vein isolation by means of catheter ablation a

199 ion group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure.

200 o the atrioventricular junction, left atrial pulmonary vein junction, and freewall left ventricle of

201 The pulmonary vein-left atrial (PV-LA) junction is key in pa

202 aintained by localized foci originating from pulmonary vein-left atrium interfaces.

203 s of the crista terminalis/pectinate muscle, pulmonary veins/left atrium.

204 Together with pulmonary veins, many extrapulmonary vein areas may be t

205 h AF referred for cardiac magnetic resonance pulmonary vein mapping before pulmonary vein isolation w

206 roducing high CF during left atrial (LA) and pulmonary vein mapping; (2) determine the ability of atr

207 n of melanocyte-like cells in the atrium and pulmonary veins may contribute to atrial arrhythmias.

208 al isthmus and anterior segments of the left pulmonary veins may explain why reconnection after ablat

209 A high-density map of LA/pulmonary veins (median 328 sites) was obtained in 18 pa

210 The risk of pulmonary vein narrowing (PVN) after pulmonary vein isol

211 natomy (volume, AP diameter), anatomy of the pulmonary veins (number, ostia diameters and surface are

212 to be the only source of arrhythmia with no pulmonary veins or other extrapulmonary vein site reconn

213 The anatomical assessment of the pulmonary vein ostia and the left atrium size in compute

214 y time, 16+/-4.2 minutes) were formed at the pulmonary vein ostia, and 6.5+/-1.3 lesions (radiofreque

215 circular electroporation ablation in porcine pulmonary vein ostia, but the relationship between the m

216 Between-subject variability of the pulmonary vein ostial cross-sectional area and the left

217 = 17) or both (n = 14) atria during superior pulmonary vein pacing at cycle lengths (CL) accelerating

218 a3d) mediates endothelial cell repulsion and pulmonary vein patterning during embryogenesis.

219 stepwise catheter ablation (isolation of the pulmonary veins plus substrate modification) from 2006 t

220 left ventricular preparations as well as in pulmonary vein preparations.

221 = 14): After a right thoracotomy, atrial and pulmonary vein programmed pacing at 2x and 4x threshold

222 s initiated when triggered activity from the pulmonary veins propagates into atrial tissue and degrad

223 should be performed prophylactically for all pulmonary veins, prophylactic SVC isolation (SVCI) is st

224 Rapid pulmonary vein (PV) activity has been shown to maintain

225 Pulmonary vein (PV) and peripheral vein (Pe) blood speci

226 ng activity in the myocardium sleeves of the pulmonary vein (PV) and systemic venous return.

227 We report the outcome of pulmonary vein (PV) antrum isolation in paroxysmal atria

228 Pulmonary vein (PV) antrum isolation in patients with hy

229 Adenosine can unmask dormant pulmonary vein (PV) conduction after PV isolation.

230 d spatial patterns consistent with a role in pulmonary vein (PV) development.

231 ency stimulation identified sites initiating pulmonary vein (PV) ectopy.

232 ght to characterize the left atrial (LA) and pulmonary vein (PV) electrophysiological and hemodynamic

233 ose and image quality in patients undergoing pulmonary vein (PV) imaging.

234 The anatomic origins of FAT were the right pulmonary vein (PV) in 3 patients, mitral annulus, crist

235 F) at different anatomic sites during antral pulmonary vein (PV) isolation for atrial fibrillation.

236 n catheters have been designed to facilitate pulmonary vein (PV) isolation in patients with paroxysma

237 e of the technical difficulty with achieving pulmonary vein (PV) isolation in the treatment of patien

238 Atrial fibrillation recurrence after pulmonary vein (PV) isolation is associated with PV to l

239 freedom from atrial fibrillation (AF) after pulmonary vein (PV) isolation using cryoballoon ablation

240 ort-standing persistent atrial fibrillation, pulmonary vein (PV) isolation was performed using the se

241 recurrence of atrial fibrillation (AF) after pulmonary vein (PV) isolation who underwent a subsequent

242 Acute pulmonary vein (PV) isolation with CB only was achieved

243 Twenty-six dogs underwent pulmonary vein (PV) isolation.

244 mplication associated with cryoballoon-based pulmonary vein (PV) isolation.

245 nd clinical performance of this catheter for pulmonary vein (PV) isolation.

246 sed incidence of arrhythmia recurrence after pulmonary vein (PV) isolation.

247 chnology designed to achieve single-delivery pulmonary vein (PV) isolation.

248 Thermodynamics in the left atrium-pulmonary vein (PV) junction, phrenic nerve, and esophag

249 In addition to extrasystoles of pulmonary vein (PV) origin, those arising from the super

250 ress (>/=90th percentile) were common at the pulmonary vein (PV) ostia (93%), the appendage ridge (10

251 Radiofrequency ablation inside pulmonary vein (PV) ostia can cause PV stenosis.

252 ated for paroxysmal atrial fibrillation, the pulmonary vein (PV) reconnection rate is substantial and

253 inent re-entrant driver regions included the pulmonary vein (PV) regions and inferoposterior left atr

254 The mechanism of pulmonary vein (PV) triggers of atrial fibrillation rema

255 hick tissues relevant to cryoablation of the pulmonary vein (PV).

256 roducibility of anatomical evaluation of the pulmonary veins (PV) and the left atrium (LA) using comp

257 Pulmonary veins (PVs) and left atrium (LA) play a critic

258 Electric isolation of the pulmonary veins (PVs) can successfully treat patients wi

259 ast rotors in the left atrium (LA) or at the pulmonary veins (PVs) is not fully understood.

260 expressed in cardiomyocytes surrounding the pulmonary veins (PVs), but its contribution to atopic as

261 equency ablation demonstrated left atrial to pulmonary vein reconduction.

262 Pulmonary vein reconnection (PVR) still determines recur

263 Pulmonary vein reconnection after pulmonary vein isolati

264 vein isolation for AF and is associated with pulmonary vein reconnection and the emergence of new tri

265 injury, providing a potential mechanism for pulmonary vein reconnection, resulting in arrhythmia rec

266 ivation sites arising predominantly from the pulmonary vein region.

267 lar capillary dysplasia with misalignment of pulmonary veins remain uncharacterized because of lack o

268 significantly reduces the risk of subsequent pulmonary vein restenosis in comparison with BA.

269 tion, mitral E' and E'/A', septal E' and A', pulmonary vein S and D wave velocities, and LV basal glo

270 ution for improved assessment of LV, LA, and pulmonary vein scar.

271 ers in the interatrial septum and around the pulmonary veins, scattered within the wall of the great

272 erated by ectopic stimuli originating in the pulmonary vein sleeves.

273 The frequency of pulmonary vein stenosis (PVS) after ablation for atrial

274 Pulmonary vein stenosis (PVS) is a rare condition that c

275 s among patients who underwent transcatheter pulmonary vein stent implantation for congenital or post

276 Median age at the time of pulmonary vein stent implantation was 1.4 years.

277 +/-8% at 1 year and 50+/-8% at 5 years after pulmonary vein stent implantation.

278 Images were analyzed as pairs of pulmonary veins to quantify the percentage of circumfere

279 l isolated antral surface area excluding the pulmonary veins to the sum of the total isolated antral

280 to be further refined with a focus on extra pulmonary vein triggers and concomitant flutters to impr

281 ed for reentry, we hypothesized that AF from pulmonary vein triggers might initiate at sites exhibiti

282 Isolation of the pulmonary veins using a multielectrode ablation catheter

283 ncture, sheath flushing, catheter insertion, pulmonary vein venography, and sheath exchange) and 333

284 cases, a second cryoapplication in the same pulmonary vein was safely performed.

285 ver agreement for the detection of accessory pulmonary veins was good (kappa=0.73; 95% CI, 0.54-0.93)

286 Fs during ablation around the right and left pulmonary veins were 22.8g (12.6-37.9; q1-q3) and 12.3g

287 Pulmonary veins were assessed for PAPVR or TAPVR, PDA, c

288 Outcomes were better if the pulmonary veins were encircled (OR, 0.26; 95% CI, 0.09-0

289 Accessory pulmonary veins were found in 24% of patients.

290 A total of 192 pulmonary veins were identified, and 191 of 192 (99%) pu

291 All pulmonary veins were isolated in both groups.

292 All pulmonary veins were isolated without steam pop, impedan

293 All target pulmonary veins were isolated.

294 Ablations of the pulmonary veins were performed in 18 swine with echo mon

295 A total of 74 pulmonary veins were stented with bare metal, drug-eluti

296 veins were identified, and 191 of 192 (99%) pulmonary veins were successfully isolated.

297 s initiated by applied ectopic pacing in the pulmonary veins, which led to the generation of localize

298 nal MIL design, connecting the left inferior pulmonary vein with the mitral annulus.

299 rategy is likely to combine isolation of the pulmonary veins with limited linear ablation within the

300 ateral MIL design, connecting the left-sided pulmonary veins with the mitral annulus along the poster